Search research articles
Contact Us
Filters
Showing results (71-80 of 821) with videos related to
Page
of 83
Sort By:
European Heart Journal
|
October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patients
Douglas S Jacoby, Daniel J Rader
Biochimica Et Biophysica Acta
|
June 17, 2014
Genetics of lipid traits: Genome-wide approaches yield new biology and clues to causality in coronary artery disease
Sumeet A Khetarpal, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2012
Approach to the patient with extremely low HDL-cholesterol
Daniel J Rader, Emil M deGoma
Journal of the American College of Cardiology
|
July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?
Emil M deGoma, Daniel J Rader
Clinical Chemistry
|
March 15, 2013
Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?
Stephen R Master, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 15, 2013
Cholesterol efflux capacity: full steam ahead or a bump in the road?
Amit V Khera, Daniel J Rader
Journal of the American College of Cardiology
|
February 11, 2017
Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?
Adnan K Chhatriwalla, Daniel J Rader
Cell Metabolism
|
April 9, 2020
Systematically Sifting Big Data to Identify Novel Causal Genes for Human Traits
Nicholas J Hand, Daniel J Rader
The Lancet. Neurology
|
December 29, 2015
Human genetics shines a light on ischaemic stroke
Benjamin F Voight, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 10, 2015
Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics
Sumeet A Khetarpal, Daniel J Rader
Page
of 83
Search research articles
Search
Showing results (71-80 of 821) with videos related to
Sort By:
Page
of 83
European Heart Journal
|
October 16, 2016
Improving cardiovascular outcomes by intensifying low density lipoprotein lowering therapy in high-risk patients
Douglas S Jacoby, Daniel J Rader
Biochimica Et Biophysica Acta
|
June 17, 2014
Genetics of lipid traits: Genome-wide approaches yield new biology and clues to causality in coronary artery disease
Sumeet A Khetarpal, Daniel J Rader
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2012
Approach to the patient with extremely low HDL-cholesterol
Daniel J Rader, Emil M deGoma
Journal of the American College of Cardiology
|
July 17, 2012
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?
Emil M deGoma, Daniel J Rader
Clinical Chemistry
|
March 15, 2013
Beyond LDL cholesterol in assessing cardiovascular risk: apo B or LDL-P?
Stephen R Master, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 15, 2013
Cholesterol efflux capacity: full steam ahead or a bump in the road?
Amit V Khera, Daniel J Rader
Journal of the American College of Cardiology
|
February 11, 2017
Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?
Adnan K Chhatriwalla, Daniel J Rader
Cell Metabolism
|
April 9, 2020
Systematically Sifting Big Data to Identify Novel Causal Genes for Human Traits
Nicholas J Hand, Daniel J Rader
The Lancet. Neurology
|
December 29, 2015
Human genetics shines a light on ischaemic stroke
Benjamin F Voight, Daniel J Rader
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 10, 2015
Triglyceride-rich lipoproteins and coronary artery disease risk: new insights from human genetics
Sumeet A Khetarpal, Daniel J Rader
Page
of 83